About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Contact
X
LinkedIn
Contact Us

The Latest

Newsroom

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Recent Posts

8/5/2024
BigHat named to the 2024’s Fierce Biotech 15
Announcements
6/27/2024
BigHat’s Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle Forward
Announcements
4/24/2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
2/27/2024
BigHat’s CIO on Software Engineering Daily podcast
Announcements
12/5/2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
10/26/2023
BigHat on Genetic Engineering & Biotechnology News
Press
8/2/2023
BigHat’s CSO on Biocom CA’s Lifelines Podcast
Announcements
6/8/2023
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023
Presentations
6/1/2023
BigHat Appoints John Corbin, PhD as Chief Development Officer
Announcements
12/21/2022
BigHat Year in Review 2022
Announcements
11/29/2022
BigHat Biosciences Announces Research Collaboration with Merck
Announcements
9/29/2022
BigHat Biosciences validates best-in-class security posture with spotless SOC2 audit
Announcements
Contact
1900 Alameda de las Pulgas
Suite 400
San Mateo, CA 94403
Navigation
About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Social
X
LinkedIn
© BigHat Bio 2026